UnitedHealth Group Incorporated (UNH)
UnitedHealth's Q3 Earnings Preview: A Tactical Opportunity Of Note
UnitedHealth Group Incorporated's Q3 earnings report is due October 15th. We expect sustained gross income from a favorable insurance pricing environment. However, claims remain unpredictable. Lower interest rates, tight credit spreads, and compressed SOFRs provide an enhanced asset-liability outlook.
What Trends Will Drive UnitedHealth's Q3?
UnitedHealth Group (NYSE: UNH) is scheduled to report its Q2 2024 results on Tuesday, October 15. We expect UnitedHealth to post revenue of $99 billion and earnings of $6.95 on a per-share and adjusted basis, slightly below the street expectations.
Unlocking Q3 Potential of UnitedHealth (UNH): Exploring Wall Street Estimates for Key Metrics
Evaluate the expected performance of UnitedHealth (UNH) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
UnitedHealth Pre-Q3 Earnings: Golden Opportunity or Fool's Gold?
UNH's third-quarter earnings are likely to have benefited from growing premiums, partially offset by higher expenses.
CVS, UnitedHealth ask for FTC's Khan and 2 commissioners to be disqualified from case
CVS Health and UnitedHealth Group have asked U.S. Federal Trade Commission chair Lina Khan and commissioners Rebecca Kelly Slaughter and Alvaro Bedoya to disqualify themselves from an FTC lawsuit that has accused the companies of unlawfully inflating insulin prices.
Here's Why UnitedHealth Group (UNH) Fell More Than Broader Market
In the most recent trading session, UnitedHealth Group (UNH) closed at $583.56, indicating a -1.29% shift from the previous trading day.
UnitedHealth Group Incorporated (UNH) Is a Trending Stock: Facts to Know Before Betting on It
UnitedHealth (UNH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Why UnitedHealth Group (UNH) Outpaced the Stock Market Today
UnitedHealth Group (UNH) concluded the recent trading session at $584.68, signifying a +0.49% move from its prior day's close.
Wall Street Bulls Look Optimistic About UnitedHealth (UNH): Should You Buy?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
UnitedHealth Vs. CVS Vs. Cigna: Which Health Stock Will Beat The FTC's Regulatory Heat?
With the Federal Trade Commission (FTC) taking a scalpel to the pharmacy benefit managers (PBMs) of UnitedHealth Group Inc UNH, CVS Health Corp CVS and Cigna Group CI, investors are left wondering which health giant can best weather the storm.
UnitedHealth, CVS Caremark, Express Scripts sued by FTC over skyrocketing insulin prices
The FTC sued UnitedHealth Group's Optum unit, CVS Caremark and Cigna's Express Scripts for allegedly steering diabetes patients towards higher priced insulin.
UnitedHealth at 19.09X P/E: Worth the Price or Time to Take Profits?
With expansion into targeted markets and strategic diversification, UNH still has significant growth potential left.
